Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion type Assertion NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_head.
- NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion description "[ZnT8 was therefore proposed as a therapeutic target for diabetes, and recent genome-wide association studies identified polymorphisms in the ZNT8 gene conferring increased type 2 diabetes risk.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_provenance.
- NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion evidence source_evidence_literature NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_provenance.
- NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion SIO_000772 19095428 NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_provenance.
- NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion wasDerivedFrom befree-20140225 NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_provenance.
- NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_assertion wasGeneratedBy ECO_0000203 NP383402.RAh9Oy5BhG4F6POwmoeayw03fd4BxjqD0iltb87ju4-48130_provenance.